Presence of the 5,10-Methylenetetrahydrofolate Reductase C677T Mutation in Puerto Rican Patients With Neural Tube Defects

Abstract

Folic acid supplementation can reduce the incidence of neural tube defects. The first reported genetic risk factor for neural tube defects is a C677T mutation in the 5,10-methylenetetrahydrofolate reductase gene, resulting in decreased activity of the enzyme. We examined the enzyme mutation role of methylenetetrahydrofolate reductase in the etiology of neural tube defects in our population. The study group consisted of 204 Puerto Rican individuals including 37 pregnant females with a prenatal diagnosis of neural tube defects in their fetuses, 31 newborns, 36 fathers, and 100 healthy adults. The prevalence of the C677T mutation was examined. Homozygosity for the alanine to valine substitution (TT) was observed in 9% of the controls and 19% of the mothers with children with neural tube defects. Our results indicate that the presence of the T allele at the methylenetetrahydrofolate reductase 677 position may increase the risk of giving birth to an infant with a neural tube defect. (J Child Neurol 2002;17:30-32).

Get full access to this article

View all access options for this article.

References

van der Put Nmj , Steegers-Theunissen Rpm , Frosst P. , et al: Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995;346:1070-1071.

Rozen R. : Genetics of mammalian 5,10 methylenetetrahydrofolate reductase, in Graham I , Refsum H , Rosenberg IH , Ueland PM (eds): Homocysteine Metabolism: From Basic Science to Clinical Medicine . Boston, Kluwer Academic Publishers , 1997, 37-42.

van der Put Nmj , Eskes Tkab , Blom HJ : Is the common 677C-T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis. QJM 1997;90:111-115.

Puerto Rico Health Department Folic Acid Campaign and Neural Tube Defects Registry 1996. Press release, San Juan, Puerto Rico, Feb 8, 1998.

Frosst P. , Blom H. , Milos R. , et al: A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-113.

Centers for Disease Control and Prevention : Use of folic acid for prevention of spina bifida and other neural tube defects 1983-1991. MMWR Morb Mortal Wkly Rep 1991;40:513-516.

Holmes LB : Prevention of neural tube defects. J Pediatr 1992; 120:918-919.

Milunsky A. , Jick H. , Jick SS , et al: Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 1989;262:2847-2852.

Smithells RW , Nevin NC , Seller MJ , et al: Further experience of vitamin supplementation for prevention of neural tube defect recurrences . Lancet 1983;1:1027-1031.

10.

Mulinare J. , Cordero, J. , Erickson D. , Berry R. : Periconceptional use of vitamins and the occurrence of neural tube defects. JAMA 1998 ;260:3141-3145.

11.

Shaw GM , Velie EM , Wasserman CR : Risk for neural tube defect-affected pregnancies among women of Mexican descent and white women in California Am JPublic Health 1997;87:1467-1471.

12.

Khoshnood B. , Singh JK , Sriram S. , et al: Birth prevalence of neural tube defects among several racial/ethnic groups in the United States. Poster presentation at the Pediatric Academy Societies' Annual Meeting, Washington, DC, May 1997.

13.

Feuchtbaum LB , Currier RJ , Riggle S. , et al: Neural tube defect prevalence in California (1990-1994): Eliciting patterns by type of defect and maternal race/ethnicity . Genet Test 1999;3:265-272.

14.

Whitehead AS , Gallagher P. , Mills JL , et al: A genetic defect in 5,10-methylenetetrahydrofolate reductase in neural tube defects. QJM 1995 ;88:763-766.

15.

Shields DC , Kirke PN , Mills JL , et al: The thermolabile variant of methylenetetrahydrofolate and neural tube defects: An evaluation of genetic risk and relative importance of the genotypes of the embryo and the mother. Am J Hum Genet 1999;64:1045-1055.

16.

van der Put Nmj , Gabreels F. , Stevens Emb , et al: A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998;62:1044-1051.